908 Devices (MASS) Cash & Current Investments (2020 - 2026)
908 Devices (MASS) posted quarterly Cash & Current Investments of $111.7 million for Q1 2026, down 10.11% year-over-year from $124.3 million in Q1 2025, and down 1.09% quarter-over-quarter from $113.0 million in Q4 2025.
908 Devices (MASS) Cash & Current Investments (2020 - 2026) Analysis & Trends
908 Devices (MASS) has reported Cash & Current Investments for 7 consecutive years, with $111.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 10.11% year-over-year to $111.7 million; the TTM figure through Mar 2026 stood at $111.7 million (down 10.11% YoY), while the FY2025 annual figure was $113.0 million, up 63.91% from the prior year.
- Cash & Current Investments eased to $111.7 million in Q1 2026 per MASS's latest filing, from $113.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $223.1 million in Q1 2022 and bottomed at $68.9 million in Q4 2024.
- Historically, Cash & Current Investments has averaged $138.7 million across 5 years, with a median of $134.2 million in 2024.
- Annual changes were most pronounced in 2024 — Cash & Current Investments sank 52.69% — and 2025, when it jumped 63.91%.
- 908 Devices' Cash & Current Investments stood at $188.4 million in 2022, then fell by 22.68% to $145.7 million in 2023, then tumbled by 52.69% to $68.9 million in 2024, then surged by 63.91% to $113.0 million in 2025, then retreated by 1.09% to $111.7 million in 2026.
- Business Quant data shows MASS's Cash & Current Investments at $111.7 million in Q1 2026, $113.0 million in Q4 2025, and $112.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 482.30 Mn |
| 10 | 908 Devices | 387.46 Mn | 285.93 Mn | 8.34 Mn | 101.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.53 Mn |
| Mar 31, 2026 | 111.74 Mn |
| Dec 31, 2025 | 112.97 Mn |
| Sep 30, 2025 | 112.05 Mn |
| Jun 30, 2025 | 118.58 Mn |
| Mar 31, 2025 | 124.32 Mn |
| Dec 31, 2024 | 68.92 Mn |
| Sep 30, 2024 | 71.69 Mn |
| Jun 30, 2024 | 77.38 Mn |
| Mar 31, 2024 | 134.20 Mn |
| Dec 31, 2023 | 145.68 Mn |
| Sep 30, 2023 | 147.90 Mn |
| Jun 30, 2023 | 152.69 Mn |
| Mar 31, 2023 | 161.21 Mn |
| Dec 31, 2022 | 188.42 Mn |
| Sep 30, 2022 | 193.70 Mn |
| Jun 30, 2022 | 212.99 Mn |
| Mar 31, 2022 | 223.12 Mn |
| Dec 31, 2021 | 224.07 Mn |
| Sep 30, 2021 | 138.82 Mn |